Contact this trialFirst, we need to learn more about you.
Janus Kinase (JAK) Inhibitor
Baricitinib for Cardiac Sarcoidosis
Recruiting1 awardPhase 2
Palo Alto, California
This trial aims to see if using a medication called baricitinib along with another medication can help treat a condition called active cardiac sarcoidosis in adults. The trial will investigate if baricitin
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service